TY - JOUR
T1 - EndoCompass Project
T2 - Research Roadmap for Thyroid Endocrinology
AU - Piekielko-Witkowska, Agnieszka
AU - Elisei, Rossella
AU - Léger, Juliane
AU - Bendlova, Bela
AU - Bulanová Pekova, Barbora
AU - Caron, Philippe
AU - Durante, Cosimo
AU - Fassnacht, Martin
AU - Feldt-Rasmussen, Ulla
AU - Filipsson Nyström, Helena
AU - Jansen, Heleen
AU - Köhrle, Josef
AU - Kus, Aleksander
AU - Ludgate, Marian
AU - Mertens, Jonathan
AU - Oczko-Wojciechowska, Małgorzata
AU - Peters, Catherine
AU - Schoenmakers, Nadia
AU - Stoupa, Athanasia
AU - van Santen, Hanneke
AU - Trimboli, Pierpaolo
AU - van Trotsenburg, Paul
AU - Visser, W. Edward
N1 - © 2025 The Author(s). Published by S. Karger AG, Basel.
PY - 2025
Y1 - 2025
N2 - BACKGROUND: Endocrine science remains underrepresented in European Union research programs despite the fundamental role of hormone health in human well-being. Analysis of the CORDIS database reveals a persistent gap between the societal impact of endocrine disorders and their research prioritization. At national funding level, endocrine societies report limited or little attention of national research funding toward endocrinology. The EndoCompass project - a joint initiative between the European Society of Endocrinology and the European Society of Paediatric Endocrinology, aimed to identify and promote strategic research priorities in endocrine science to address critical hormone-related health challenges. METHODS: Research priorities were established through comprehensive analysis of the EU CORDIS database covering the Horizon 2020 framework period (2014-2020). Expert consultation in thyroid endocrinology was conducted to identify key research priorities, followed by broader stakeholder engagement including society members and patient advocacy groups. RESULTS: For thyroid disorders, research priorities encompass neoplastic and nonneoplastic conditions, focusing on disease mechanisms, improved diagnostics and treatments, and the impact of environmental and metabolic factors. Key areas include personalized medicine approaches, artificial intelligence applications, and the establishment of pan-European registries to advance understanding of rare thyroid conditions. CONCLUSIONS: The thyroid component of the EndoCompass project provides an evidence-based roadmap for strategic research investment. This framework identifies crucial investigation areas into thyroid disease pathophysiology, prevention, and treatment strategies, ultimately aimed at reducing the burden of thyroid disorders on individuals and society. The findings support the broader EndoCompass objective of aligning research funding with areas of highest potential impact in endocrine health.
AB - BACKGROUND: Endocrine science remains underrepresented in European Union research programs despite the fundamental role of hormone health in human well-being. Analysis of the CORDIS database reveals a persistent gap between the societal impact of endocrine disorders and their research prioritization. At national funding level, endocrine societies report limited or little attention of national research funding toward endocrinology. The EndoCompass project - a joint initiative between the European Society of Endocrinology and the European Society of Paediatric Endocrinology, aimed to identify and promote strategic research priorities in endocrine science to address critical hormone-related health challenges. METHODS: Research priorities were established through comprehensive analysis of the EU CORDIS database covering the Horizon 2020 framework period (2014-2020). Expert consultation in thyroid endocrinology was conducted to identify key research priorities, followed by broader stakeholder engagement including society members and patient advocacy groups. RESULTS: For thyroid disorders, research priorities encompass neoplastic and nonneoplastic conditions, focusing on disease mechanisms, improved diagnostics and treatments, and the impact of environmental and metabolic factors. Key areas include personalized medicine approaches, artificial intelligence applications, and the establishment of pan-European registries to advance understanding of rare thyroid conditions. CONCLUSIONS: The thyroid component of the EndoCompass project provides an evidence-based roadmap for strategic research investment. This framework identifies crucial investigation areas into thyroid disease pathophysiology, prevention, and treatment strategies, ultimately aimed at reducing the burden of thyroid disorders on individuals and society. The findings support the broader EndoCompass objective of aligning research funding with areas of highest potential impact in endocrine health.
KW - Biomedical Research
KW - Child
KW - Endocrinology
KW - Humans
KW - Thyroid Diseases/therapy
UR - https://www.scopus.com/pages/publications/105024732711
U2 - 10.1159/000549075
DO - 10.1159/000549075
M3 - Review article
C2 - 41325413
AN - SCOPUS:105019114482
SN - 1663-2818
VL - 98
SP - 144
EP - 157
JO - Hormone research in paediatrics
JF - Hormone research in paediatrics
IS - Suppl. 2
ER -